Moreover, increased Chk1 activity has been shown to correlate with radio- and chemo-resistance in multiple cancers and inhibition of Chk1 sensitizes colon cancer cells to cisplatin [25] and pancreatic cancer cells to gemcitabine [26]. This evidence concerns the gene CHEK1 and colonic neoplasm.